pieris.com (PVLA) Company Sales Volume

Corporate emblem and logo of pieris.com (PVLA)

To minimize raw material supply disruptions, Pieris Pharmaceuticals (PVLA) is diversifying its laboratory network by leveraging the outsourcing of production and research to CMOs and CROs. The company's sales statistics demonstrate demand dynamics, where the value 0.00 describes the current revenue level. The development strategy is based on creating innovative therapies for cancer and respiratory pathologies through large-scale partnerships with global pharma behemoths.

PVLA Pieris Pharma: Company Revenue in the range 07/04/2022 - 11/16/2026

Comprehensive metric breakdowns and analytics for pieris.com (PVLA)

- price and consensus price forecast:
Comprehensive company analysis:Pieris Pharmaceuticals - PVLA
Manufactured product of Pieris Pharmaceuticals

Sales serve as a fundamental indicator of market demand for the issuer's products. Analyzing the company's commercial revenue allows for the tracking of daily cash flow dynamics. This metric aggregates daily sales volumes, determining the current financial stability of the business. For Pieris Pharmaceuticals (PVLA), this figure reflects the intensity of incoming licensing payments. Increasing values confirm the demand for anti-calin technologies among the largest pharmaceutical behemoths.

Key competitors

Revenue and Sales Volume argenx.com|Company Revenue BioNTech Group (BNTX)|Abivax S.A. - Company Sales Volume|Revenue and Sales Volume ADMA (admabiologics.com)|Protagonist Corp (PTGX) - Company Total Revenue|immunovant.com - Revenue and Sales Volume|KNSA - Revenue and Sales Volume|Grifols (GRFS) - Company Revenue|Company Sales Volume ADPT|Company Revenue Celldex|AUPH: Company Sales Revenue|Revenue and Sales Volume BCRX|Revenue and Sales Volume Vera Therapeutics (VERA)|Dianthus Therapeutics - Company Sales|Pharvaris - Company Revenue|ABCL - Company Revenue|TRML - Revenue and Sales Volume|PGEN: Revenue and Sales Volume|Company Sales Volume PHAR|Company Sales NKTR|UPB: Company Sales Revenue|Company Revenue zenasbio.com (ZBIO)|IMNM (Immunome Corp) - Company Sales Revenue|Revenue and Sales Volume GOSS (Gossamer Bio, Inc.)|KALV (KalVista Pharmaceuticals) - Company Annual Revenue|SEPN - Company Revenue|Company Gross Revenue Savara Inc SVRA|RIGL: Revenue and Sales Volume|ANAB - Company Gross Revenue|Company Revenue Astria Pharma|Company Sales Volume ENGN (enGene Holdings Inc.)|Company Sales RAPT (RAPT Therapeutics, Inc.)|Revenue and Sales Volume Aerovate Therapeutics, Inc. (JBIO)|Revenue and Sales Volume ACRS (aclaristx.com)|Kyverna Therapeutics (KYTX) - Company Total Revenue|tizianalifesciences.com - Revenue and Sales Volume|CABA (Cabaletta Bio, Inc.) - Company Sales Volume|VTYX: Revenue and Sales Volume|THTX - Company Gross Revenue|Company Revenue Avalo Therapeutics Inc|Eledon (ELDN) - Company Gross Revenue|Company Revenue agenusbio.com (AGEN)|CLYM (Climb Bio Inc) - Company Sales Revenue|Revenue and Sales Volume ZURA (zurabio.com)|Company Sales Revenue ATYR|ADAG - Company Revenue|ikenaoncology.com (IMA) - Company Sales|Shattuck Labs (STTK) - Company Revenue|EQ - Company Gross Revenue|CNTB (connectbiopharm.com) - Revenue and Sales Volume|IMUX: Company Sales Revenue|Company Revenue Atara Biotherapeutics, Inc. (ATRA)|Company Gross Revenue InflaRx NV|Revenue and Sales Volume XFOR (X4 Pharmaceuticals)|Revenue and Sales Volume Adicet Bio ACET|CELU: Company Sales|Company Sales Revenue INMB (INmune Bio)|Barinthus Bio (BRNS) - Company Revenue|Kezar Life Sciences (KZR) - Revenue and Sales Volume|Company Revenue sabbiotherapeutics.com|Revenue and Sales Volume Akari Therapeutics Plc|Company Revenue Enlivex Therapeutics Ltd (ENLV)|Q32 Bio Corp (QTTB) - Company Total Sales Volume|Company Revenue GeoVax Corp GOVX|Company Gross Revenue Edesa Biotech Corp (EDSA)|IBIO: Company Sales|Company Sales Revenue CARM (carismatx.com)|XTLB: Revenue and Sales Volume|BOLT - Company Gross Revenue|Company Sales HCWB|Company Sales Aptevo Therapeutics Inc. (APVO)|Revenue and Sales Volume AIM|ADTX: Company Annual Revenue|GRI Bio - Company Sales|Company Gross Revenue XORTX Therapeutics Inc (XRTX)|HIND: Company Sales|Revelation Biosciences (REVB) - Company Sales|Indaptus Therapeutics, Inc. (INDP) - Company Revenue|SCNI - Company Gross Revenue|CALI (CalciMedica) - Revenue and Sales Volume|Revenue and Sales Volume affimed.com|Company Revenue Allakos Therapeutics (ALLK)|HOOK - Company Total Revenue|Company Revenue IGM Biosciences, Inc. IGMS|Company Gross Revenue iTeos Therapeutics, Inc. (ITOS)|Ocean Biomedical Corp - Revenue and Sales Volume|TC BioPharm (TCBP) - Company Sales|THRD: Revenue and Sales Volume